Advertisement.

APTOF Projected Dividend Yield

Aptose Biosciences Inc ( OTCBB : APTOF )

Aptose Biosciences is a clinical-stage biotechnology company focused on developing precision medicines for oncology, particularly hematology. Its pipeline includes small molecule cancer therapeutics designed for single-agent efficacy and to enhance other anti-cancer therapies without overlapping toxicities. The lead compound, Tuspetinib, is an oral kinase inhibitor showing activity as a monotherapy and in combination for relapsed or refractory acute myeloid leukemia (AML), and is being developed for newly diagnosed AML. Luxeptinib targets B-cell malignancies like chronic lymphocytic leukemia, and certain non-Hodgkin's lymphomas resistant to conventional treatments.

21 YEAR PERFORMANCE RESULTS

APTOF Dividend History Detail
APTOF Dividend News
APTOF Competitors News

# of Shares: 0

Closing Price: 1.50

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000